Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab and chemotherapy in locally advanced rectal cancer
NCT01434147Phase 2Completed
- Sponsor
- Austrian Breast and Colorectal Cancer Study Group
- Start
- Oct 2011
- Primary completion
- Aug 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in rectal cancer, sponsored by Austrian Breast and Colorectal Cancer Study Group. Started Oct 2011; status: completed.
02
Drugs
bevacizumab
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT01434147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01434147.